SCHEMBL6984975

SCHEMBL6984975

N#Cc1ccc(CCC(=O)N2CCc3cc([N+](=O)[O-])ccc32)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.57
KCNJ1 P48048 2/20 0.53
KCNH2 Q12809 2/20 0.53
TP53 P04637 2/20 0.49
DRD2 P14416 1/20 0.47
MAPT P10636 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 3/20 0.46
MAPK1 P28482 2/20 0.46
RAB9A P51151 2/20 0.46
HTR2C P28335 1/20 0.45
SLC6A9 P48067 1/20 0.43
SLC6A5 Q9Y345 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
FFAR1 O14842 1/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 1/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7956735 0.94 KCNJ1 (0.51) DRD4KCNJ1KCNH2TP53DRD2
SCHEMBL6983845 0.84 KCNJ1 (0.45) DRD4KCNJ1KCNH2TP53MAPT
SCHEMBL6975443 0.83 TP53 (0.54) TP53MAPTSMN1; SMN2NPC1MAPK1
SCHEMBL6980061 0.82 KCNJ1 (0.47) DRD4KCNJ1KCNH2TP53MAPT
SCHEMBL15784265 0.81 DRD4 (0.59) DRD4DRD2MAPTSMN1; SMN2NPC1
SCHEMBL6646056 0.78 DRD4 (0.64) DRD4DRD2MAPTSMN1; SMN2NPC1
SCHEMBL6979722 0.77 TP53 (0.48) TP53MAPTSMN1; SMN2NPC1MAPK1
SCHEMBL7959087 0.77 TP53 (0.48) TP53MAPTSMN1; SMN2NPC1MAPK1
SCHEMBL6981640 0.76 NR3C1 (0.47) TP53SMN1; SMN2MAPK1L3MBTL1LMNA
SCHEMBL27888907 0.76 HTR2C (0.58) DRD4DRD2MAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed